A narrative review on perioperative systemic therapy in non-small cell lung cancer
Non-small cell lung cancer (NSCLC) that is operable still carries a high risk of recurrence, approaching 50% of all operable cases despite adding adjuvant chemotherapy. However, the utilization of immunotherapy and targeted therapy moving beyond the metastatic NSCLC setting and into early-stage peri...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
Open Exploration Publishing Inc.,
2024-07-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|